OncologyDr. Rajesh Kumar JainBreast Cancer

Principal Director, Surgical Oncology, BLK-Max Super Speciality Hospital, New Delhi

Part 5 of 9 in Breast Cancer - Diagnosis and Surgical Management

Axillary Management in Breast Cancer: Sentinel Biopsy and the LYMPHA Technique

September 21, 2025

When axillary nodes are not clinically or radiologically palpable, sentinel lymph node biopsy is preferred over complete axillary dissection, using methylene blue, indocyanine green, or a radiopharmaceutical tracer to identify and remove the two to four sentinel nodes in level one of the axilla. If these come back negative on frozen section, complete axillary dissection is avoided entirely; if even one is positive, complete dissection follows.

Complete dissection, when it's needed

Complete axillary dissection covers level one and two nodes as the standard extent; level three (apical) nodes are added only when nodes appear notably enlarged or when sentinel node technique isn't available or trained for. Dr. Jain personally performs a full level one-to-three dissection whenever he isn't doing sentinel node biopsy, specifically because the LYMPHA technique he pairs it with removes the downside that dissection would otherwise carry.

LYMPHA: preventing lymphoedema at the time of primary surgery

LYMPHA is a microvascular technique, performed by very few centres worldwide, in which a lateral tributary of the axillary vein is anastomosed under a microscope to a lymphatic channel in the mid-arm, identified using methylene blue injection. This adds around 20 minutes to the primary surgery but creates a drainage channel from the lymphatics into the vein, meaningfully reducing seroma formation, allowing earlier drain removal, and preventing the arm lymphoedema that would otherwise follow complete axillary clearance or axillary radiation.

This article is based on a Jivo Masterclass session conducted by Dr. Rajesh Kumar Jain, Principal Director, Surgical Oncology, BLK-Max Super Speciality Hospital, New Delhi. The article has been summarised with the assistance of an AI tool from the original masterclass recording. Watch the full Masterclass recording

Looking for a breast cancer or surgical oncology consultation or a second opinion? Get in touch with the Jivo team

This guide is based on a live Jivo Masterclass — Dr. Rajesh Kumar Jain taught doctors across Africa on September 21, 2025.

FROM THE LIVE Q&A

DR

Dr. Sunday

What is the prognosis for breast cancer treatment?

RK

Dr. Rajesh Kumar Jain

Prognosis is improving steadily. Five-year survival is around 97-98% for stage one, 90-95% for stage two, 80-85% for stage three, and even stage four disease has a 25-30% five-year survival rate. Triple-negative and locally advanced cases carry a higher recurrence risk specifically, so they need especially stringent follow-up to catch any recurrence early enough to treat.

See all 8 questions from this masterclass →

Book a Consultation with Dr. Rajesh Kumar Jain

Book on WhatsApp

Or message us on WhatsApp: +91 98182 98669

Frequently Asked Questions

What is the cost implication of breast cancer treatment?

Surgery alone, all-inclusive, costs roughly $5,000. Chemotherapy adds around $10,000, and radiation is roughly $3,500 to $4,000. Extended targeted therapy such as trastuzumab can add another $10,000, though that portion can often be continued at the patient's home location. As a rough guide, surgery plus basic chemotherapy runs around $15,000 for most patients, and cases involving genuine financial hardship can always be discussed.

Other than PET CT, how can breast cancer be staged using ultrasound and CT scan in a limited setup?

A whole-abdomen ultrasound, not just the upper abdomen, checks for liver metastasis and also covers the ovaries and uterus. A chest X-ray checks for lung metastasis. For bone, a skeletal survey, plain X-rays covering the spine, skull and limbs, substitutes for a bone scan where nuclear medicine isn't available. This combination is less accurate than PET CT but is a reasonable, optimal fallback when resources are limited.

For a young unmarried woman with a well-localised, mobile, unilateral lump at stage two or three ductal carcinoma, which surgery is advisable, and can a pre-menopausal patient start tamoxifen before or after surgery?

For a young patient with early, well-localised disease, breast conservation surgery is advisable over mastectomy: a wide excision with lymph node dissection or sentinel biopsy, followed by pathology review. If the oestrogen receptor is positive on the final specimen, tamoxifen is started after surgery, and chemotherapy is added if indicated by the pathology. Starting tamoxifen before surgery is not advisable.

Is it possible to start chemotherapy in the patient's home country before sending them for further evaluation and management?

Neoadjuvant chemotherapy should be started before referral in two situations: triple-negative breast cancer, and locally advanced disease, meaning a tumour over 5 cm, ulceration, peau d'orange skin change, satellite nodules, or bulky or supraclavicular nodes. In locally advanced disease, surgery follows after around four to four and a half months of chemotherapy. In genuinely advanced or metastatic disease, treatment is systemic only, chemotherapy or hormone therapy, with no surgery. For anything in between, it is always better to discuss the specific case jointly before deciding independently whether and when to start treatment.

If it is familial, should bilateral surgery be done without any further testing?

No, a BRCA1 and BRCA2 test should be done first. Indications for testing are all triple-negative breast cancer, a strong first-degree family history (a sister, mother, or maternal or paternal aunt with breast cancer), and any history of male breast cancer in the family, which alone is enough to warrant testing. If the BRCA test comes back positive, mastectomy of the affected breast should be combined with prophylactic mastectomy of the opposite side. If BRCA testing isn't available locally, it can be arranged through Dr. Jain's centre.

When is sentinel lymph node biopsy preferred over complete axillary dissection?

When axillary nodes are not clinically or radiologically palpable. Two to four sentinel nodes are removed and checked on frozen section; if negative, complete dissection is avoided, if even one is positive, complete dissection follows.

What is the LYMPHA technique and what does it prevent?

A microvascular technique performed at the time of primary axillary surgery, anastomosing a lymphatic channel in the arm to a tributary of the axillary vein under a microscope. It adds around 20 minutes to surgery but prevents the arm lymphoedema that would otherwise follow complete axillary clearance or radiation.

Need Expert Medical Guidance?

Connect with leading specialists through the Jivo Healthcare network for personalized advice.

Get Expert Opinion